CN1222524C - 5-[4-[2-[n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的新多晶型形态及其制备方法 - Google Patents

5-[4-[2-[n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的新多晶型形态及其制备方法 Download PDF

Info

Publication number
CN1222524C
CN1222524C CNB018174302A CN01817430A CN1222524C CN 1222524 C CN1222524 C CN 1222524C CN B018174302 A CNB018174302 A CN B018174302A CN 01817430 A CN01817430 A CN 01817430A CN 1222524 C CN1222524 C CN 1222524C
Authority
CN
China
Prior art keywords
thiazolidine
methyl
benzyl
pyridyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018174302A
Other languages
English (en)
Chinese (zh)
Other versions
CN1535271A (zh
Inventor
P·舍比亚姆
R·S·马来拉佩利
V·克里希纳穆尔蒂
V·R·希拉
O·R·加达姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Research Foundation
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Research Foundation filed Critical Dr Reddys Research Foundation
Publication of CN1535271A publication Critical patent/CN1535271A/zh
Application granted granted Critical
Publication of CN1222524C publication Critical patent/CN1222524C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB018174302A 2000-09-26 2001-09-25 5-[4-[2-[n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的新多晶型形态及其制备方法 Expired - Fee Related CN1222524C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN805/MAS/00 2000-09-26
IN805MA2000 2000-09-26

Publications (2)

Publication Number Publication Date
CN1535271A CN1535271A (zh) 2004-10-06
CN1222524C true CN1222524C (zh) 2005-10-12

Family

ID=34308054

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018174302A Expired - Fee Related CN1222524C (zh) 2000-09-26 2001-09-25 5-[4-[2-[n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的新多晶型形态及其制备方法

Country Status (6)

Country Link
KR (1) KR20030082541A (ko)
CN (1) CN1222524C (ko)
AU (1) AU2001291232B8 (ko)
IL (1) IL155036A (ko)
RU (1) RU2286345C2 (ko)
UA (1) UA75370C2 (ko)

Also Published As

Publication number Publication date
AU2001291232B8 (en) 2006-12-21
AU2001291232B2 (en) 2006-11-16
CN1535271A (zh) 2004-10-06
KR20030082541A (ko) 2003-10-22
UA75370C2 (en) 2006-04-17
IL155036A (en) 2011-11-30
RU2286345C2 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
CN1026322C (zh) 苯并哑唑衍生物的制备方法
CN1083830C (zh) 经取代的苄脒,其制备及作为药物化合物的用途
CN1167702C (zh) 5-[4-[2-n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的多晶型物
CN1208335C (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
CN101039917A (zh) 制备替米沙坦的方法
JP2004509961A (ja) 5−[4−[2−[n−メチル−n−(2−ピリジル)アミノ]エトキシ]ベンジル]チアゾリジン−2,4−ジオンマレイン酸塩の新規の多型形態およびそれらの調製方法
CN1285831A (zh) 取代的噻唑烷二酮衍生物,其制备过程及其药学用途
CN1152878C (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
CN1009826B (zh) 制备喹啉基化合物的方法
CN1886371A (zh) 氟伐他汀钠多晶型物的制备方法
CN1222524C (zh) 5-[4-[2-[n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的新多晶型形态及其制备方法
CN1863799A (zh) 治疗糖尿病和脂质紊乱的色原烷羧酸衍生物
US7241895B2 (en) Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
JP2010248246A (ja) 5−[4−[[3−メチル−4−オキソ−3,4−ジヒドロキナゾリン−2−イル]メトキシ]ベンジル]チアゾリジン−2,4−ジオンカリウム塩の新規な結晶形
CN100342851C (zh) 包含西布曲明甲磺酸盐半水合物晶体的药物组合物
CN100345846C (zh) 5-[4-[2-(n-甲基-n-(2-吡啶基)氨基)乙氧基]苄基]噻唑烷-2,4-二酮的钠盐
CN1098258C (zh) 异香豆素衍生物及其在医药上的应用
CN1814599A (zh) 一种噻唑烷二酮衍生物以及其作为抗糖尿病药的应用
CN1326449A (zh) 5-[{6-(2-氟苄基)氧基-2-萘基}甲基]-2,4-噻唑烷二酮的晶体
WO2002028857A1 (en) Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
CN101048416A (zh) 有机化合物
CN1443185A (zh) 药用的5-(4-(2-(n-甲基-n-(2-吡啶基)氨基)乙氧基)苄基)噻唑烷-2,4-二酮氢碘化物
AU2001291232A1 (en) Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
CN102977085A (zh) 2-芳基-苯并[d]噁唑、2-芳基-苯并[d]噻唑衍生物及其制备方法和用途
JP2005523300A5 (ko)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee